{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:30:08Z","timestamp":1787160608528,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00234-019-02198-w","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T10:02:16Z","timestamp":1553335336000},"page":"711-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1263-3393","authenticated-orcid":false,"given":"Pierre","family":"Marsault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Menut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bessou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Havez-Enjolras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Chateil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,23]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.crad.2017.11.005","volume":"73","author":"JR Young","year":"2018","unstructured":"Young JR, Orosz I, Franke MA, Kim HJ, Woodworth D, Ellingson BM, Salamon N, Pope WB (2018) Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration. Clin Radiol 73:290\u2013295. \nhttps:\/\/doi.org\/10.1016\/j.crad.2017.11.005","journal-title":"Clin Radiol"},{"key":"2198_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1148\/radiol.14140364","volume":"275","author":"T Kanda","year":"2015","unstructured":"Kanda T, Osawa M, Oba H, Toyoda K, Kotoku J\u2019, Haruyama T, Takeshita K, Furui S (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:803\u2013809","journal-title":"Radiology"},{"key":"2198_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/RLI.0000000000000072","volume":"49","author":"Y Errante","year":"2014","unstructured":"Errante Y, Cirimele V, Mallio CA, di Lazzaro V, Zobel BB, Quattrocchi CC (2014) Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Investig Radiol 49:685\u2013690. \nhttps:\/\/doi.org\/10.1097\/RLI.0000000000000072","journal-title":"Investig Radiol"},{"key":"2198_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiol.2015150337","volume":"275","author":"A Radbruch","year":"2015","unstructured":"Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P, Heiland S, Wick W, Schlemmer HP, Bendszus M (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275:783\u2013791. \nhttps:\/\/doi.org\/10.1148\/radiol.2015150337","journal-title":"Radiology"},{"key":"2198_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1148\/radiol.2016160356","volume":"282","author":"TF Flood","year":"2017","unstructured":"Flood TF, Stence NV, Maloney JA, Mirsky DM (2017) Pediatric brain: repeated exposure to linear gadolinium-based contrast material is associated with increased signal intensity at unenhanced T1-weighted MR imaging. Radiology 282:222\u2013228. \nhttps:\/\/doi.org\/10.1148\/radiol.2016160356","journal-title":"Radiology"},{"key":"2198_CR6","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s00247-016-3646-3","volume":"46","author":"HH Hu","year":"2016","unstructured":"Hu HH, Pokorney A, Towbin RB, Miller JH (2016) Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams. Pediatr Radiol 46:1590\u20131598. \nhttps:\/\/doi.org\/10.1007\/s00247-016-3646-3","journal-title":"Pediatr Radiol"},{"key":"2198_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/RLI.0000000000000419","volume":"53","author":"DM Renz","year":"2018","unstructured":"Renz DM, K\u00fcmpel S, B\u00f6ttcher J, Pfeil A, Streitparth F, Waginger M, Reichenbach JR, Teichgr\u00e4ber UK, Mentzel HJ (2018) Comparison of unenhanced T1-weighted signal intensities within the dentate nucleus and the globus pallidus after serial applications of gadopentetate dimeglumine versus gadobutrol in a pediatric population. Investig Radiol 53:119\u2013127. \nhttps:\/\/doi.org\/10.1097\/RLI.0000000000000419","journal-title":"Investig Radiol"},{"key":"2198_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1148\/radiol.2015150872","volume":"276","author":"J Ramalho","year":"2015","unstructured":"Ramalho J, Castillo M, AlObaidy M, Nunes RH, Ramalho M, Dale BM, Semelka RC (2015) High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents. Radiology 276:836\u2013844. \nhttps:\/\/doi.org\/10.1148\/radiol.2015150872","journal-title":"Radiology"},{"key":"2198_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00330-015-3879-9","volume":"26","author":"DA Stojanov","year":"2016","unstructured":"Stojanov DA, Aracki-Trenkic A, Vojinovic S, Benedeto-Stojanov D, Ljubisavljevic S (2016) Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol 26:807\u2013815. \nhttps:\/\/doi.org\/10.1007\/s00330-015-3879-9","journal-title":"Eur Radiol"},{"key":"2198_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1148\/radiol.2017170391","volume":"285","author":"A Bj\u00f8rnerud","year":"2017","unstructured":"Bj\u00f8rnerud A, Vatnehol SAS, Larsson C, Due-T\u00f8nnessen P, Hol PK, Groote IR (2017) Signal enhancement of the dentate nucleus at unenhanced MR imaging after very high cumulative doses of the macrocyclic gadolinium-based contrast agent gadobutrol: an observational study. Radiology 285:434\u2013444. \nhttps:\/\/doi.org\/10.1148\/radiol.2017170391","journal-title":"Radiology"},{"key":"2198_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1148\/radiol.15150025","volume":"275","author":"RJ McDonald","year":"2015","unstructured":"McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772\u2013782. \nhttps:\/\/doi.org\/10.1148\/radiol.15150025","journal-title":"Radiology"},{"key":"2198_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/jamapediatrics.2017.0264","volume":"171","author":"JS McDonald","year":"2017","unstructured":"McDonald JS, McDonald RJ, Jentoft ME et al (2017) Intracranial gadolinium deposition following gadodiamide-enhanced magnetic resonance imaging in pediatric patients: a case-control study. JAMA Pediatr 171:705\u2013707. \nhttps:\/\/doi.org\/10.1001\/jamapediatrics.2017.0264","journal-title":"JAMA Pediatr"},{"key":"2198_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1148\/radiol.2016152846","volume":"281","author":"N Maximova","year":"2016","unstructured":"Maximova N, Gregori M, Zennaro F, Sonzogni A, Simeone R, Zanon D (2016) Hepatic gadolinium deposition and reversibility after contrast agent-enhanced MR imaging of pediatric hematopoietic stem cell transplant recipients. Radiology 281:418\u2013426. \nhttps:\/\/doi.org\/10.1148\/radiol.2016152846","journal-title":"Radiology"},{"key":"2198_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/RLI.0000000000000266","volume":"51","author":"DR Roberts","year":"2016","unstructured":"Roberts DR, Lindhorst SM, Welsh CT, Maravilla KR, Herring MN, Adam Braun K, Thiers BH, Davis WC (2016) High levels of gadolinium deposition in the skin of a patient with normal renal function. Investig Radiol 51:280\u2013289. \nhttps:\/\/doi.org\/10.1097\/RLI.0000000000000266","journal-title":"Investig Radiol"},{"key":"2198_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","volume":"51","author":"N Murata","year":"2016","unstructured":"Murata N, Gonzalez-Cuyar LF, Murata K, Fligner C, Dills R, Hippe D, Maravilla KR (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with Normal renal function. Investig Radiol 51:447\u2013453. \nhttps:\/\/doi.org\/10.1097\/RLI.0000000000000252","journal-title":"Investig Radiol"},{"key":"2198_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/01.rli.0000186569.32408.95","volume":"41","author":"GW White","year":"2006","unstructured":"White GW, Gibby WA, Tweedle MF (2006) Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Investig Radiol 41:272\u2013278. \nhttps:\/\/doi.org\/10.1097\/01.rli.0000186569.32408.95","journal-title":"Investig Radiol"},{"key":"2198_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/jama.2016.8096","volume":"316","author":"B Welk","year":"2016","unstructured":"Welk B, McArthur E, Morrow SA, MacDonald P, Hayward J, Leung A, Lum A (2016) Association between gadolinium contrast exposure and the risk of parkinsonism. JAMA 316:96\u201398. \nhttps:\/\/doi.org\/10.1001\/jama.2016.8096","journal-title":"JAMA"},{"key":"2198_CR18","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1007\/s00247-018-4154-4","volume":"48","author":"E Maloney","year":"2018","unstructured":"Maloney E, Stanescu AL, Perez FA, Iyer RS, Otto RK, Leary S, Steuten L, Phipps AI, Shaw DWW (2018) Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary? Pediatr Radiol 48:1472\u20131484. \nhttps:\/\/doi.org\/10.1007\/s00247-018-4154-4","journal-title":"Pediatr Radiol"},{"key":"2198_CR19","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","volume":"23","author":"MJ Binning","year":"2007","unstructured":"Binning MJ, Liu JK, Kestle JRW, Brockmeyer DL, Walker ML (2007) Optic pathway gliomas: a review. Neurosurg Focus 23:E2. \nhttps:\/\/doi.org\/10.3171\/FOC-07\/11\/E2","journal-title":"Neurosurg Focus"},{"key":"2198_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/ICU.0000000000000370","volume":"28","author":"N Rasool","year":"2017","unstructured":"Rasool N, Odel JG, Kazim M (2017) Optic pathway glioma of childhood. Curr Opin Ophthalmol 28:289\u2013295. \nhttps:\/\/doi.org\/10.1097\/ICU.0000000000000370","journal-title":"Curr Opin Ophthalmol"},{"key":"2198_CR21","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro-oncology 19:v1\u2013v88. \nhttps:\/\/doi.org\/10.1093\/neuonc\/nox158","journal-title":"Neuro-oncology"},{"key":"2198_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1586\/ern.09.4","volume":"9","author":"AC Albers","year":"2009","unstructured":"Albers AC, Gutmann DH (2009) Gliomas in patients with neurofibromatosis type 1. Expert Rev Neurother 9:535\u2013539. \nhttps:\/\/doi.org\/10.1586\/ern.09.4","journal-title":"Expert Rev Neurother"},{"key":"2198_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2013.8.PEDS12546","volume":"13","author":"J Goodden","year":"2014","unstructured":"Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, Thorp N, Mallucci C (2014) The role of surgery in optic pathway\/hypothalamic gliomas in children. J Neurosurg Pediatr 13:1\u201312. \nhttps:\/\/doi.org\/10.3171\/2013.8.PEDS12546","journal-title":"J Neurosurg Pediatr"},{"key":"2198_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-016-2163-4","volume":"129","author":"MJ Wan","year":"2016","unstructured":"Wan MJ, Ullrich NJ, Manley PE, Kieran MW, Goumnerova LC, Heidary G (2016) Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1. J Neuro-Oncol 129:173\u2013178. \nhttps:\/\/doi.org\/10.1007\/s11060-016-2163-4","journal-title":"J Neuro-Oncol"},{"key":"2198_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189\u2013198. \nhttps:\/\/doi.org\/10.1002\/ana.21107","journal-title":"Ann Neurol"},{"key":"2198_CR26","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncology 17:iv1\u2013iv62. \nhttps:\/\/doi.org\/10.1093\/neuonc\/nov189","journal-title":"Neuro-Oncology"},{"key":"2198_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. \nhttps:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"2198_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/08830738030180070401","volume":"18","author":"E Czyzyk","year":"2003","unstructured":"Czyzyk E, J\u00f3\u017awiak S, Roszkowski M, Schwartz RA (2003) Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 18:471\u2013478. \nhttps:\/\/doi.org\/10.1177\/08830738030180070401","journal-title":"J Child Neurol"},{"key":"2198_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00381-016-3262-4","volume":"33","author":"S Gaudino","year":"2017","unstructured":"Gaudino S, Martucci M, Russo R, Visconti E, Gangemi E, D\u2019Argento F, Verdolotti T, Lauriola L, Colosimo C (2017) MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma. Childs Nerv Syst 33:35\u201354. \nhttps:\/\/doi.org\/10.1007\/s00381-016-3262-4","journal-title":"Childs Nerv Syst"},{"key":"2198_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000120454","volume":"15","author":"K Sato","year":"1989","unstructured":"Sato K, Rorke LB (1989) Vascular bundles and wickerworks in childhood brain tumors. Pediatr Neurosci 15:105\u2013110","journal-title":"Pediatr Neurosci"},{"key":"2198_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1148\/radiology.189.1.8372197","volume":"189","author":"MJ Fulham","year":"1993","unstructured":"Fulham MJ, Melisi JW, Nishimiya J, Dwyer AJ, di Chiro G (1993) Neuroimaging of juvenile pilocytic astrocytomas: an enigma. Radiology 189:221\u2013225. \nhttps:\/\/doi.org\/10.1148\/radiology.189.1.8372197","journal-title":"Radiology"},{"key":"2198_CR32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00234-012-1010-3","volume":"54","author":"S Gaudino","year":"2012","unstructured":"Gaudino S, Quaglio FR, Schiarelli C, Martucci M, Tartaglione T, Gualano MR, di Lella GM, Colosimo C (2012) Spontaneous modifications of contrast enhancement in childhood non-cerebellar pilocytic astrocytomas. Neuroradiology 54:989\u2013995. \nhttps:\/\/doi.org\/10.1007\/s00234-012-1010-3","journal-title":"Neuroradiology"},{"key":"2198_CR33","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","volume":"14","author":"MJ Fisher","year":"2012","unstructured":"Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology 14:790\u2013797. \nhttps:\/\/doi.org\/10.1093\/neuonc\/nos076","journal-title":"Neuro-Oncology"},{"key":"2198_CR34","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ophtha.2011.12.035","volume":"119","author":"JP Kelly","year":"2012","unstructured":"Kelly JP, Leary S, Khanna P, Weiss AH (2012) Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas. Ophthalmology 119:1231\u20131237. \nhttps:\/\/doi.org\/10.1016\/j.ophtha.2011.12.035","journal-title":"Ophthalmology"},{"key":"2198_CR35","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/pbc.25480","volume":"62","author":"B Shofty","year":"2015","unstructured":"Shofty B, Mauda-Havakuk M, Weizman L, Constantini S, Ben-Bashat D, Dvir R, Pratt LT, Joskowicz L, Kesler A, Yalon M, Ravid L, Ben-Sira L (2015) The effect of chemotherapy on optic pathway gliomas and their sub-components: a volumetric MR analysis study. Pediatr Blood Cancer 62:1353\u20131359. \nhttps:\/\/doi.org\/10.1002\/pbc.25480","journal-title":"Pediatr Blood Cancer"},{"key":"2198_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1259\/bjr\/65246351","volume":"81","author":"T Taylor","year":"2008","unstructured":"Taylor T, Jaspan T, Milano G et al (2008) Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol 81:761\u2013766. \nhttps:\/\/doi.org\/10.1259\/bjr\/65246351","journal-title":"Br J Radiol"},{"key":"2198_CR37","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","volume":"79","author":"HW Dodge","year":"1958","unstructured":"Dodge HW, Love JG, Craig WM et al (1958) Gliomas of the optic nerves. AMA Arch Neurol Psychiatry 79:607\u2013621","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"2198_CR38","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/FOC-07\/11\/E1","volume":"23","author":"AG Lee","year":"2007","unstructured":"Lee AG (2007) Neuroophthalmological management of optic pathway gliomas. Neurosurg Focus 23:E1. \nhttps:\/\/doi.org\/10.3171\/FOC-07\/11\/E1","journal-title":"Neurosurg Focus"},{"key":"2198_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00234-015-1612-7","volume":"58","author":"J Lambron","year":"2016","unstructured":"Lambron J, Rakotonjanahary J, Loisel D, Frampas E, de Carli E, Delion M, Rialland X, Toulgoat F (2016) Can we improve accuracy and reliability of MRI interpretation in children with optic pathway glioma? Proposal for a reproducible imaging classification. Neuroradiology 58:197\u2013208. \nhttps:\/\/doi.org\/10.1007\/s00234-015-1612-7","journal-title":"Neuroradiology"},{"key":"2198_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.media.2011.07.001","volume":"16","author":"L Weizman","year":"2012","unstructured":"Weizman L, Ben Sira L, Joskowicz L, Constantini S, Precel R, Shofty B, Ben Bashat D (2012) Automatic segmentation, internal classification, and follow-up of optic pathway gliomas in MRI. Med Image Anal 16:177\u2013188. \nhttps:\/\/doi.org\/10.1016\/j.media.2011.07.001","journal-title":"Med Image Anal"},{"key":"2198_CR41","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1200\/JCO.2001.19.2.551","volume":"19","author":"AG Sorensen","year":"2001","unstructured":"Sorensen AG, Patel S, Harmath C, Bridges S, Synnott J, Sievers A, Yoon YH, Lee EJ, Yang MC, Lewis RF, Harris GJ, Lev M, Schaefer PW, Buchbinder BR, Barest G, Yamada K, Ponzo J, Kwon HY, Gemmete J, Farkas J, Tievsky AL, Ziegler RB, Salhus MRC, Weisskoff R (2001) Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19:551\u2013557. \nhttps:\/\/doi.org\/10.1200\/JCO.2001.19.2.551","journal-title":"J Clin Oncol"},{"key":"2198_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.compmedimag.2004.07.008","volume":"29","author":"J Liu","year":"2005","unstructured":"Liu J, Udupa JK, Odhner D, Hackney D, Moonis G (2005) A system for brain tumor volume estimation via MR imaging and fuzzy connectedness. Comput Med Imaging Graph 29:21\u201334. \nhttps:\/\/doi.org\/10.1016\/j.compmedimag.2004.07.008","journal-title":"Comput Med Imaging Graph"},{"key":"2198_CR43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1148\/radiol.13131669","volume":"270","author":"T Kanda","year":"2014","unstructured":"Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834\u2013841. \nhttps:\/\/doi.org\/10.1148\/radiol.13131669","journal-title":"Radiology"},{"key":"2198_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11547-017-0816-9","volume":"123","author":"A Splendiani","year":"2018","unstructured":"Splendiani A, Perri M, Marsecano C, Vellucci V, Michelini G, Barile A, di Cesare E (2018) Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients. Radiol Med 123:125\u2013134. \nhttps:\/\/doi.org\/10.1007\/s11547-017-0816-9","journal-title":"Radiol Med"},{"key":"2198_CR45","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/RLI.0b013e3181852171","volume":"43","author":"T Frenzel","year":"2008","unstructured":"Frenzel T, Lengsfeld P, Schirmer H, H\u00fctter J, Weinmann HJ (2008) Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Investig Radiol 43:817\u2013828. \nhttps:\/\/doi.org\/10.1097\/RLI.0b013e3181852171","journal-title":"Investig Radiol"},{"key":"2198_CR46","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/jon.12450","volume":"27","author":"N Jittapiromsak","year":"2017","unstructured":"Jittapiromsak N, Hou P, Liu H-L, Sun J, Slopis JM, Chi TL (2017) Prognostic role of conventional and dynamic contrast-enhanced MRI in optic pathway gliomas: conventional and DCE MRI in optic pathway glioma. J Neuroimaging 27:594\u2013601. \nhttps:\/\/doi.org\/10.1111\/jon.12450","journal-title":"J Neuroimaging"},{"key":"2198_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2214\/ajr.161.2.8333380","volume":"161","author":"JA Strong","year":"1993","unstructured":"Strong JA, Hatten HP, Brown MT et al (1993) Pilocytic astrocytoma: correlation between the initial imaging features and clinical aggressiveness. Am J Roentgenol 161:369\u2013372. \nhttps:\/\/doi.org\/10.2214\/ajr.161.2.8333380","journal-title":"Am J Roentgenol"}],"updated-by":[{"DOI":"10.1007\/s00234-019-02214-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000}}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-019-02198-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00234-019-02198-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-019-02198-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T20:26:55Z","timestamp":1584822415000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00234-019-02198-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,23]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1007\/s00234-019-02198-w","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,23]]},"assertion":[{"value":"1 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the article \u201cDiagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children\u201d, Table 2 data were not presented correctly, with results placed beneath an incorrect heading. Confidence interval also added. The original article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}